Page last updated: 2024-10-27

fenvalerate and Experimental Mammary Neoplasms

fenvalerate has been researched along with Experimental Mammary Neoplasms in 1 studies

fenvalerate: synthetic pyrethroid; RN given refers to cpd without isomeric designation; structure
fenvalerate : A carboxylic ester obtained by formal condensation between 2-(4-chlorophenyl)-3-methylbutyric acid and cyano(3-phenoxyphenyl)methanol.

Research Excerpts

ExcerptRelevanceReference
"Body weight was decreased and organ/body weight ratios were increased in brain, liver, spleen, kidneys (females), heart (females), and testes (males) in the 1000 ppm group."1.27Chronic toxicity and carcinogenicity evaluation of fenvalerate in rats. ( Gordon, EB; Hall, WC; Parker, CM; Patterson, DR; Valerio, MG; Van Gelder, GA, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parker, CM1
Patterson, DR1
Van Gelder, GA1
Gordon, EB1
Valerio, MG1
Hall, WC1

Other Studies

1 other study available for fenvalerate and Experimental Mammary Neoplasms

ArticleYear
Chronic toxicity and carcinogenicity evaluation of fenvalerate in rats.
    Journal of toxicology and environmental health, 1984, Volume: 13, Issue:1

    Topics: Administration, Oral; Animals; Body Weight; Carcinogens; Female; Male; Mammary Neoplasms, Experiment

1984